Published on 29/11/2025

Cleanroom Classification for ATMP Suites

Introduction to Cleanroom Classification in ATMP Facilities

As the biopharmaceutical landscape continues to expand, particularly in the area of Advanced Therapy Medicinal Products (ATMP), the importance of stringent cleanroom classifications cannot be overstated. Aseptic processing environments are critical for maintaining the quality and safety of biologics, necessitating compliance with FDA, EMA, and other regulatory standards. This article aims to provide pharma professionals with a comprehensive step-by-step guide on cleanroom classification tailored specifically for ATMP suites, focusing on essential elements such as viral clearance validation, spiking studies, and the implications of aseptic controls as outlined in Annex 1 of the EU Guidelines.

The Importance of Cleanroom Classification for ATMPs

Cleanroom classification is vital for ensuring the integrity and safety of ATMP products. The classification of cleanrooms is defined by their allowable levels of airborne particulate contamination, which is crucial in creating a suitable environment for the production of viral therapies, gene therapies, and cell-based products. According to ICH Q5A(R2), maintaining a controlled environment minimizes contamination risks, which, in turn, supports the overall efficacy and safety of the finished product.

Cleanrooms are categorized according to the maximum allowable levels of airborne contaminants and are critical in the context of biological potency identity CQAs (critical quality attributes). The cleanroom classifications typically range from ISO Class 1 to ISO Class 9, with lower classifications allowing fewer particulates. The higher the classification, the cleaner the environment, which may be necessary for more sensitive ATMPs.

Step 1: Understanding Regulatory Requirements

Understanding and complying with regulatory requirements is the first step in the cleanroom classification process. Various regulations and guidelines exist, such as the FDA’s 21 CFR Part 211 and the EMA’s Guidelines on Good Manufacturing Practice (GMP). These documents outline the necessary cGMP practices for the manufacturing of ATMPs. The most relevant factors include:

• Aseptic Processing Requirements: Cleanrooms must adhere to strict standards for contamination control, ensuring that all operations maintain sterility.
• Personnel and Operations: Implementation of specific personnel practices is crucial to mitigate contamination risks. This includes training, gowning procedures, and movement patterns within cleanrooms.
• Validation Protocols: Each cleanroom must have a validation protocol to confirm its classification, including regular monitoring of particulate levels and environmental controls.

Additionally, the recently updated EMA guidelines (Annex 1) elaborates on various aseptic controls and their implications for the cleanliness and integrity of ATMP manufacturing environments.

Step 2: Conducting Initial Risk Assessment

The second step involves conducting a thorough risk assessment to evaluate potential contamination sources within the cleanroom environment. This risk assessment should include:

• Assessment of Materials and Equipment: Examine all materials and equipment used in the cleanroom. Closed systems and single-use technologies can significantly reduce contamination risks and are often recommended in ATMP processing.
• Evaluation of Processes: Review all manufacturing processes to determine potential contamination points, considering processes like filling, packaging, and storage.
• Personnel Interaction: Understand the impact of personnel movements on contamination risks. Implement protocols that limit foot traffic and use of the cleanroom.

After identifying potential contamination risks, create a plan to mitigate these risks. Integrating single-use systems for fluid transfers can significantly reduce the risks associated with traditional connection points.

Step 3: Selection of Cleanroom Classification Standards

The selection of cleanroom classification standards is a crucial step in ensuring compliance with regulatory expectations. ATMP manufacturing typically necessitates higher classification standards due to the sensitive nature of the products involved. The most commonly accepted cleanroom classifications include:

• ISO Class 5: Typically used for critical aseptic processes, allowing up to 3,520 particles of size 0.5 micrometers or larger per cubic meter.
• ISO Class 7: Permitting up to 352,000 particles of size 0.5 micrometers or larger per cubic meter, this classification is often sufficient for less critical processes.
• ISO Class 8: Commonly utilized for operations that are less sensitive to particulate contamination.

Ensure the chosen classification aligns with the intended use of the ATMP product. For instance, aseptic products might require an ISO Class 5 environment, while other biologics could function effectively in a Class 7 cleanroom. Understanding the rationale behind these classifications will aid in specifying the proper conditions for viral clearance validation and other critical quality measures.

Step 4: Implementation of Environmental Monitoring Protocols

The next step in cleanroom classification is establishing effective environmental monitoring protocols. These protocols ensure the ongoing assessment of cleanroom performance, helping to maintain compliance with regulatory standards. Key elements include:

• Regular Air Sampling: Implement an air sampling strategy that monitors particulate levels at established frequency intervals. The sampling frequency must be determined based on the cleanroom classification.
• Surface Monitoring: Regularly check surfaces for microbial and particulate contamination. Swab assays can be employed to evaluate critical surfaces and ensure they remain within acceptable limits.
• Temperature and Humidity Monitoring: Maintain control of temperature and humidity levels that can impact product stability and sterility.

Establishing a comprehensive environmental monitoring plan will contribute to effective aseptic processing while also aiding in the alignment with WHO recommendations for cleanroom environments.

Step 5: Conducting Validation of Cleaning Procedures

Effective cleaning procedures are pivotal in maintaining the integrity of cleanroom environments, especially within ATMP suites. Cleaning validation should ensure all cleaning metrics are robust and capable of preventing contamination. This step includes:

• Cleaning Agent Selection: Reference regulatory guidelines for the selection of cleaning agents to ensure they are compatible with the specific bioproducts and do not interfere with viral clearance validation.
• Establishment of Cleaning Procedures: Define cleaning protocols detailing the steps required for cleaning surfaces, equipment, and tools. This must also include validation of cleaning techniques.
• Cleaning Verification: After cleaning, surfaces should be tested for residues of cleaning agents and microbial contamination to confirm effectiveness. Validated methods such as ATP bioluminescence assays can be employed to monitor cleanliness.

Cleaning validation should be cyclic and incorporate routine assessments as part of a quality assurance program to maintain compliance with Good Manufacturing Practice (GMP) standards.

Step 6: Execution of Qualification Studies

Once cleaning procedures have been validated, proceed with execution qualification studies for the cleanroom. This encompasses several profound practices, such as:

• Installation Qualification (IQ): Ensure all system components and subsystems are installed correctly and meet the operational requirements.
• Operational Qualification (OQ): Test and verify that processes perform consistently and reliably as per specifications. This includes assessing airflow designs and uniformity.
• Performance Qualification (PQ): Evaluate the cleanroom performance under actual operating conditions, simulating production runs to gather data regarding the effectiveness of controls.

Incorporating closed systems during operations can improve the overall reliability of these studies by reducing exposure risks during manufacturing. Completing these qualification studies will build a robust validation package for regulatory submissions.

Step 7: Continuous Monitoring and Improvement

The final step in cleanroom classification for ATMP suites is establishing protocols for ongoing monitoring and continuous improvement. Key practices include:

• Adoption of Quality Risk Management (QRM) approaches: Implement active feedback loops from monitoring data to enhance processes continually.
• Periodic Revalidation: Schedule regular assessments of cleanroom classifications and processes to adapt to changes in product specifications or regulatory requirements.
• Training and Development: Ensure staff are regularly retrained on aseptic techniques and new technologies related to single-use systems and closed manufacturing processes.

Continuous improvement is critical for maintaining compliance and ensuring the high-quality standards requisite of ATMP manufacturing environments. Adhering to rigorous PPQ (Process Performance Qualification) and CPV (Continued Process Verification) principles will also bolster product integrity throughout its lifecycle.

Conclusion

In conclusion, cleanroom classification is a critical component of ATMP manufacturing. By following this comprehensive step-by-step guide, pharmaceutical professionals can enhance their understanding of cleanroom standards, ensuring regulatory compliance while also addressing the specific needs of biologics and ATMP products. A robust cleanroom classification strategy, focused on viral clearance validation, implements best practices surrounding aseptic controls, thereby safeguarding product quality and patient safety.